Physical	O
activity	O
patterns	O
and	O
associations	O
with	O
health	O
-	O
related	O
quality	O
of	O
life	O
in	O
bladder	B:C0005695
cancer	I:C0005695
survivors	O
.	O

Physical	O
activity	O
has	O
been	O
shown	O
to	O
significantly	O
improve	B:C0184511
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQOL	O
)	O
and	O
survivorship	O
in	O
a	O
variety	O
of	O
patients	O
with	O
cancer	O
.	O

Physical	O
activity	O
has	O
been	O
shown	O
to	O
significantly	O
improve	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQOL	O
)	O
and	O
survivorship	O
in	O
a	O
variety	O
of	O
patients	O
with	O
cancer	B:C0006826
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
physical	O
activity	O
patterns	O
of	O
bladder	B:C0005695
cancer	I:C0005695
survivors	O
and	O
how	O
these	O
are	O
related	O
to	O
HRQOL	O
in	O
the	O
United	O
States	I:C0041703
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
physical	O
activity	O
patterns	O
of	O
bladder	O
cancer	I:C0005695
survivors	O
and	O
how	O
these	O
are	O
related	O
to	O
HRQOL	O
in	O
the	O
United	B:C0041703
States	I:C0041703
.	O

Our	O
objective	O
was	O
to	O
describe	O
self	O
-	O
reported	O
physical	O
activity	O
patterns	O
and	O
HRQOL	O
and	O
examine	B:C0332128
the	O
association	O
between	O
these	O
measures	O
in	O
a	O
large	O
cohort	O
of	O
bladder	O
cancer	I:C0005695
survivors	O
.	O

Our	O
objective	O
was	O
to	O
describe	O
self	O
-	O
reported	O
physical	O
activity	O
patterns	O
and	O
HRQOL	O
and	O
examine	O
the	O
association	O
between	O
these	O
measures	O
in	O
a	O
large	O
cohort	B:C0599755
of	O
bladder	O
cancer	I:C0005695
survivors	O
.	O

Our	O
objective	O
was	O
to	O
describe	O
self	O
-	O
reported	O
physical	O
activity	O
patterns	O
and	O
HRQOL	O
and	O
examine	O
the	O
association	O
between	O
these	O
measures	O
in	O
a	O
large	O
cohort	O
of	O
bladder	B:C0005695
cancer	I:C0005695
survivors	O
.	O

In	O
this	O
cross-sectional	B:C0010362
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	B:C0005695
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	B:C0242356
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	B:C0038951
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	B:C3899181
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	B:C3899181
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	B:C0282574
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
long	O
-	O
term	O
bladder	O
cancer	I:C0005695
survivors	O
identified	O
through	O
an	O
institutional	O
database	O
were	O
mailed	O
a	O
survey	O
that	O
included	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
(	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
)	O
and	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
(	O
International	B:C0282574
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
)	O
.	O

Associations	O
between	O
HRQOL	O
,	O
as	O
assessed	O
by	O
the	O
Functional	B:C3899181
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
,	O
and	O
physical	O
activity	O
,	O
as	O
assessed	O
by	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
,	O
were	O
examined	O
by	O
stratified	O
analyses	O
of	O
HRQOL	O
by	O
different	O
levels	O
of	O
physical	O
activity	O
,	O
proportional	O
odds	I:C0282574
ordinal	I:C0282574
logistic	I:C0282574
regression	I:C0282574
models	I:C0282574
,	O
and	O
local	O
polynomial	I:C0282574
regression	I:C0282574
models	I:C0282574
.	O

Associations	O
between	O
HRQOL	O
,	O
as	O
assessed	O
by	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
,	O
and	O
physical	O
activity	O
,	O
as	O
assessed	O
by	O
the	O
International	B:C0282574
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
,	O
were	O
examined	O
by	O
stratified	O
analyses	O
of	O
HRQOL	O
by	O
different	O
levels	O
of	O
physical	O
activity	O
,	O
proportional	O
odds	I:C0282574
ordinal	I:C0282574
logistic	I:C0282574
regression	I:C0282574
models	I:C0282574
,	O
and	O
local	O
polynomial	I:C0282574
regression	I:C0282574
models	I:C0282574
.	O

Associations	O
between	O
HRQOL	O
,	O
as	O
assessed	O
by	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
,	O
and	O
physical	O
activity	O
,	O
as	O
assessed	O
by	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
,	O
were	O
examined	B:C0332128
by	O
stratified	O
analyses	O
of	O
HRQOL	O
by	O
different	O
levels	O
of	O
physical	O
activity	O
,	O
proportional	O
odds	I:C0282574
ordinal	I:C0282574
logistic	I:C0282574
regression	I:C0282574
models	I:C0282574
,	O
and	O
local	O
polynomial	I:C0282574
regression	I:C0282574
models	I:C0282574
.	O

Associations	O
between	O
HRQOL	O
,	O
as	O
assessed	O
by	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
,	O
and	O
physical	O
activity	O
,	O
as	O
assessed	O
by	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
,	O
were	O
examined	O
by	O
stratified	O
analyses	O
of	O
HRQOL	O
by	O
different	O
levels	O
of	O
physical	O
activity	O
,	O
proportional	B:C0282574
odds	I:C0282574
ordinal	I:C0282574
logistic	I:C0282574
regression	I:C0282574
models	I:C0282574
,	O
and	O
local	O
polynomial	I:C0282574
regression	I:C0282574
models	I:C0282574
.	O

Associations	O
between	O
HRQOL	O
,	O
as	O
assessed	O
by	O
the	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
,	O
and	O
physical	O
activity	O
,	O
as	O
assessed	O
by	O
the	O
International	O
Physical	I:C0282574
Activity	I:C0282574
Questionnaire	I:C0282574
,	O
were	O
examined	O
by	O
stratified	O
analyses	O
of	O
HRQOL	O
by	O
different	O
levels	O
of	O
physical	O
activity	O
,	O
proportional	O
odds	I:C0282574
ordinal	I:C0282574
logistic	I:C0282574
regression	I:C0282574
models	I:C0282574
,	O
and	O
local	B:C0282574
polynomial	I:C0282574
regression	I:C0282574
models	I:C0282574
.	O

A	O
total	O
of	O
472	O
subjects	O
(	O
49	O
%	O
response	O
rate	O
)	O
completed	O
the	O
survey	B:C0038951
.	O

The	O
mean	B:C0243095
age	I:C0243095
was	O
74	O
years	O
;	O
81	O
%	O
were	O
male	O
and	O
87	O
%	O
were	O
white	O
.	O

Subjects	B:C0011000
reporting	I:C0011000
"	O
high	O
"	O
physical	O
activity	O
had	O
a	O
median	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
score	O
of	O
129	O
compared	O
with	O
119	O
among	O
those	O
reporting	O
"	O
low	O
"	O
physical	O
activity	O
,	O
a	O
statistically	O
and	O
clinically	O
significant	I:C2826293
difference	O
.	O

Subjects	O
reporting	I:C0011000
"	O
high	O
"	O
physical	O
activity	O
had	O
a	O
median	O
Functional	B:C3899181
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
score	O
of	O
129	O
compared	O
with	O
119	O
among	O
those	O
reporting	O
"	O
low	O
"	O
physical	O
activity	O
,	O
a	O
statistically	O
and	O
clinically	O
significant	I:C2826293
difference	O
.	O

Subjects	O
reporting	I:C0011000
"	O
high	O
"	O
physical	O
activity	O
had	O
a	O
median	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
score	O
of	O
129	O
compared	O
with	O
119	O
among	O
those	O
reporting	B:C0011000
"	O
low	O
"	O
physical	O
activity	O
,	O
a	O
statistically	O
and	O
clinically	O
significant	I:C2826293
difference	O
.	O

Subjects	O
reporting	I:C0011000
"	O
high	O
"	O
physical	O
activity	O
had	O
a	O
median	O
Functional	O
Assessment	I:C3899181
of	I:C3899181
Cancer	I:C3899181
Therapy	I:C3899181
Bladder	I:C3899181
Cancer	I:C3899181
score	O
of	O
129	O
compared	O
with	O
119	O
among	O
those	O
reporting	O
"	O
low	O
"	O
physical	O
activity	O
,	O
a	O
statistically	O
and	O
clinically	B:C2826293
significant	I:C2826293
difference	O
.	O

Similarly	O
,	O
subjects	B:C0011000
reporting	I:C0011000
"	O
high	O
"	O
physical	O
activity	O
had	O
a	O
2.2	O
-	O
fold	O
increased	O
odds	O
of	O
reporting	O
higher	O
global	O
HRQOL	O
compared	O
with	O
subjects	O
reporting	I:C0011000
"	O
low	O
"	O
physical	O
activity	O
.	O

Similarly	O
,	O
subjects	O
reporting	I:C0011000
"	O
high	O
"	O
physical	O
activity	O
had	O
a	O
2.2	O
-	O
fold	O
increased	O
odds	O
of	O
reporting	O
higher	O
global	O
HRQOL	O
compared	O
with	O
subjects	B:C0011000
reporting	I:C0011000
"	O
low	O
"	O
physical	O
activity	O
.	O

This	O
large	O
cohort	B:C0599755
of	O
bladder	O
cancer	I:C0005695
survivors	O
reported	O
high	O
levels	O
of	O
physical	O
activity	O
.	O

This	O
large	O
cohort	O
of	O
bladder	B:C0005695
cancer	I:C0005695
survivors	O
reported	O
high	O
levels	O
of	O
physical	O
activity	O
.	O

Further	O
studies	O
investigating	O
the	O
causal	O
relationship	O
between	O
physical	O
activity	O
and	O
HRQOL	O
in	O
the	O
posttreatment	O
setting	O
in	O
bladder	B:C0005695
cancer	I:C0005695
survivors	O
are	O
warranted	O
.	O

